Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension



Rating:

Share or cite this content

Citations should be made in the following way:
B. Tielemans (Leuven, Belgium), A. Wagenaar (Leuven, Belgium), C. Belge (Leuven, Belgium), M. Delcroix (Leuven, Belgium), R. Quarck (Leuven, Belgium). In vitro effects of vasodilatory drugs on BMPR2-silenced pulmonary microvascular endothelial cell function. 586

Member's Comments

No comment yet.

Related content which might interest you: The pro-proliferative phenotype of pulmonary microvascular endothelium Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Hypoxia-induced increase in NO production and eNOS expression by murine pulmonary microvascular endothelial cells Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 Phosphodiesterase-type 3 inhibitor potentiates cAMP generation and antiproliferative effects of treprostinil in pulmonary arterial smooth muscle cells from patients with pulmonary hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Effect of targeted therapy on circulating endothelial progenitor cells in precapillary pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Implication of aquaporin-1 in the stress response of human pulmonary microvascular endothelial cells Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure Year: 2019 Mechanisms of vascular endothelial cell injury in response to intermittent and continuous hypoxia exposure and protective effects of anti-inflammatory and anti-oxidant agents Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017 Alkalosis induce eNOS activation in human pulmonary arterial endothelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 73s Year: 2001 The effect of ASK1 inhibition on hypoxia-induced pulmonary artery fibroblast activation and associated paracrine effects on vascular smooth muscle cells Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Dexamethasone induces anti-remodelling effects in rat pulmonary arterial smooth muscle cells Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Effect of BMPRII on endothelial function in human lung microvascular endothelial cells Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Iloprost protects against lung endothelial barrier dysfunction and vascular leak via Rap1 Source: Annual Congress 2009 - Crossing the line: alveolo-capillary barrier control in acute lung injury Year: 2009 Esterification of iloprost enhances its protective effects on pulmonary endothelium Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Integrity of cytoskeleton is essential for human pulmonary microvascular endothelial cell resistance against mechanical stress Source: Eur Respir J 2005; 26: Suppl. 49, 97s Year: 2005 ACE2 activation improves pulmonary endothelial function and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Antiproliferative effects of drugs affecting different signalling pathways on rat and human pulmonary artery smooth muscle cells Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Role of c-Abelson in the loss of genome integrity in endothelial cells in pulmonary arterial hypertension Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery Source: Eur Respir J 2001; 18: 5-14 Year: 2001